FDA approves Colorado plan to import selected drugs from Canada

The U.S. Food and Drug Administration approves a Colorado program that allows the state to import certain prescription drugs from Canada. The FDA’s action permits the importation of specific medicines as part of an effort to lower drug costs for residents in Colorado. The FDA frames the approval as a step toward expanding access to lower-priced alternatives while following federal requirements for drug safety and quality. The program is limited to particular prescription drugs rather than all medications, and the approval reflects FDA review of the proposed import plan. Under the approach described by the FDA, eligible drugs are sourced from Canada and brought into the United States under the rules governing prescription drug importation. The approval indicates that the federal government is allowing Colorado to move forward with the program, subject to the conditions established by the FDA. STAT reports that the intent of the plan is to reduce prices that patients pay for medicines by leveraging lower costs in the Canadian market for drugs included in the approved list.